Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)
Public ClinicalTrials.gov record NCT02598661. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Evaluate Imetelstat (GRN163L) in Transfusion-Dependent Subjects With IPSS Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) That is Relapsed/Refractory to Erythropoiesis-Stimulating Agent (ESA) Treatment
Study identification
- NCT ID
- NCT02598661
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Geron Corporation
- Industry
- Enrollment
- 289 participants
Conditions and interventions
Conditions
Interventions
- Imetelstat Sodium Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 11, 2016
- Primary completion
- Oct 12, 2023
- Completion
- Oct 12, 2026
- Last update posted
- Jan 4, 2026
2016 – 2026
United States locations
- U.S. sites
- 22
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UAB Comprehensive Cancer Center | Birmingham | Alabama | 35294 | — |
| Acrc/Arizona Clinical Research, Inc. | Tucson | Arizona | 85715 | — |
| CBCC Global Research, Inc. | Bakersfield | California | 93309 | — |
| UCLA Ronald Regan Medical Center | Los Angeles | California | 90095 | — |
| Yale-New Haven Hospital (YNHH) - Smilow Cancer Hospital | New Haven | Connecticut | 06510-3220 | — |
| BRCR Medical Center | Plantation | Florida | 33326 | — |
| University of South Florida (USF) - H. Lee Moffitt Cancer Center | Tampa | Florida | 33612 | — |
| Franciscan Health | Indianapolis | Indiana | 46237-8601 | — |
| St. Agnes Healthcare, Inc | Baltimore | Maryland | 21229 | — |
| Center for Cancer and Blood Disorders | Bethesda | Maryland | 20817 | — |
| Washington University School of Medicine | St Louis | Missouri | 63110 | — |
| University of New Mexico Cancer Center | Albuquerque | New Mexico | 87131 | — |
| Icahn School of Medicine at Mount Sinai Program for the Protection of Human Subjects | New York | New York | 10029 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Weill Cornell Medical College-New York Presbyterian Hospital | New York | New York | 10065 | — |
| Cleveland Clinic Taussig Cancer | Cleveland | Ohio | 44195 | — |
| The Ohio State Comprehensive Cancer Center | Columbus | Ohio | 43210 | — |
| Prairie lakes Healthcare system, Inc | Watertown | South Dakota | 57201 | — |
| Vanderbilt University Medical - Hematology-Oncology | Nashville | Tennessee | 37232-6307 | — |
| Texas Oncology/Methodist Charlton Cancer Center | Dallas | Texas | 75237 | — |
| Simmons Comprehensive Cancer Center | Dallas | Texas | 75390 | — |
| Fred Hutchinson Cancer Research Center (FHCRC) | Seattle | Washington | 98109-1024 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 104 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02598661, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 4, 2026 · Synced Jun 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02598661 live on ClinicalTrials.gov.